Board Members

Ian Davis, Chair

Professor Ian Davis MB BS PhD FRACP FAChPM is a medical oncologist, cancer immunologist and clinician-scientist. He is Professor of Medicine, Monash University and Eastern Health, and Head of the Eastern Health Clinical School (EHCS), where he is responsible for all clinical research within Eastern Health through the Monash Eastern Clinical Research Unit (ECRU). He holds honorary appointments with the Olivia Newton-John Cancer Research Institute (formerly Ludwig Institute for Cancer Research) and Austin Health, and is an adjunct Associate Professor of the University of Melbourne, and Associate of the University of Sydney. His primary clinical interests are in urologic cancer and in melanoma, and his primary research interests are in cancer immunology and the biology of urologic cancers. He heads the Uro-oncology Laboratory at EHCS in which basic and translational research occurs in prostate cancer, and leads the Eastern Health genitourinary cancer clinical trial program. He is the founder of the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), member of COSA Council, and previously COSA Board director. He is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP), and chair of the ANZUP Board and of its Scientific Advisory Committee.

Guy Toner, Deputy Chair

Associate Professor Guy Toner is a Consultant Medical Oncologist at Peter MacCallum Cancer Centre and Associate Professor of Medicine at the University of Melbourne. He is a graduate of the University of Melbourne and undertook sub-specialty training in medical oncology in Melbourne before spending 3 years at Memorial Sloan-Kettering Cancer Centre, New York. His clinical and research interests include all urological cancers with a particular interest in testicular cancer, which was the subject of his MD thesis. He has been an active member of other cooperative trials groups including as a past member of the Scientific Advisory Boards of the ANZ Breast Cancer Trials Group and the Australian Sarcoma Study Group. He was Head of the Medical Oncology Unit at Peter MacCallum Cancer Centre from 1993-2007. He was Chair of the ANZ Germ Cell Trials Group from 1995 until it merged to form ANZUP and since then he has been the Deputy Chair of ANZUP.

Nick Buchan

Dr Nick Buchan is a Urologist based in Christchurch, New Zealand and works in both public and private practice. Nick's practice focuses on the diagnosis and management of urological cancers. Nick gained his experience in medical trials while on fellowship at the Vancouver Prostate Centre. The Vancouver Prostate Centre is one of the largest research and clinical centres in the world that focuses on traditional research into prostatic diseases, prostate cancer in particular. Currently Nick is director of the Canterbury Urology Research Trust (CURT). CURT is a trust that conducts urological trials for CROs as well as its own investigator led trials in urological conditions with the main focus being urological oncology. Nick is also Managing Director of a large urology specialist practice, Urology Associates.

Martin Dowling

Mr Martin Dowling has held executive and senior management level financial and commercial roles at some of the largest companies in the world. He has delivered in leadership roles against a broad portfolio of responsibilities across a range of industries including mining, mining services, manufacturing and engineering. He has a Bachelor of Commerce and MBA degree and is a Fellow of CPA Australia and a graduate member of the Australian Institute of Company Directors. He is committed to the pursuit of charitable and societal goals as a Director on not-for-profit boards and also actively in the local community.

Joe Esposito

Mr Joe Esposito is a Melbourne director who has established a BOQ (Bank of Queensland) branch in the inner city suburb of Collingwood Victoria. Prior to this was a management consultant and had over 20 years in corporate banking in Australia and New Zealand. He was also CEO of ASX listed Jetset Travelworld Limited between 2003 and 2006. Mr Esposito has a close affinity with the objectives of ANZUP and the needs of consumers. He has Bachelor of Commerce and Master of Applied Finance degrees. He is a graduate member of the Australian Institute of Company Directors.

Glenn Ferguson

Mr Glenn Ferguson AM is a Solicitor of the High Court of Australia and the Supreme Court of Queensland. He is a past President of the Law Council of Australia and past President of Lawasia the law association for Asia and the Pacific and a past President of the Queensland Law Society. He is also a Senior Counsellor with the Queensland Law Society and has previously chaired their professional standards committee. Glenn is a Founding Fellow of the Australian Academy of Law, a Fellow of the Australian Institute of Company Directors and a Fellow of the Australia and New Zealand College of Notaries. He was appointed the inaugural Adjunct Professor in Law at the University of the Sunshine Coast. He is past Chair of WorkCover Queensland and is currently chair of Lexon Insurance and a Governor of the College of Law.  He has been appointed by both Federal and State Governments to various advisory boards and task forces in the legal, business and immigration sectors.

Linda Martin

Ms Linda Martin is managing director of Linda Martin Consulting, providing mentoring and coaching to executives. She has held many senior executive roles in government and was previously CEO of Musculoskeletal Australia. Linda has worked in diverse industries in the public, private and not for profit sectors, including in health, community and other service sectors. Linda’s focus has been on leading edge strategy, governance, change management and the development of strategic alliances. She is passionate about achieving consumer outcomes in health and welfare.

Shomik Sengupta 

Professor Shomik Sengupta is a consultant urologist and Director of Research & Training at Austin Health, and Clinical Professor at the Department of Surgery (Austin) of Melbourne University. Shomik has a practice with a uro-oncology subspecialty interest – including open, laparoscopic and robotic cancer surgery. He is currently the leader of the GU Oncology advisory group within USANZ and is on the Executive Committee of the Clinical Network of the Cancer Council of Victoria.. Shomik also has a strong interest in urologic research, including involvement in clinical trials through the ANZUP trials group. He has completed a Masters in Surgery (2002) and a Doctorate in Medicine (2014) through the University of Melbourne and has more than 80 original publications to date.

Henry Woo

Henry Woo is a urological surgeon who subspecialises in prostate disease.  He is the Director of Uro-Oncology and Professor of Robotic Cancer Surgery at the Chris O’Brien Lifehouse.   He is also Professor of Surgery at the Sydney Adventist Hospital Clinical School of the University of Sydney. He has published widely in major urological journals. He is an Associate Editor of the journal Prostate Cancer Prostatic Diseases and serves on the journal editorial boards of European Urology, BJUI, Prostate International, Asian Journal of Urology and World Journal of Men’s Health. He also serves on the board of the charitable Australian Urological Foundation(AUF) and is a member of the Executive Committee of the Asian Pacific Prostate Society (APPS). He is passionate about clinical trials and procuring the best evidenced based options for his patients. He also has particular interests in surgical education and the role of social media in learning and health advocacy.

Margaret McJannett, CEO Ex-officio

Ms Margaret McJannett is the Chief Executive Officer (CEO) for ANZUP Cancer Trials Group Ltd. Her professional background is in nursing with a post-graduate certificate in oncology nursing. Margaret worked as a clinical nurse consultant at The Sydney Melanoma Unit, research coordinator in the Medical Psychology Research Unit, Sydney University and project officer at the Queensland Institute of Medical Research in Brisbane. Ms McJannett more recently was the EO of the Clinical Oncological Society of Australia (COSA) and Cancer Council Australia before taking up her role with ANZUP. She has facilitated and contributed to COSA's and CCA's expert committees, the national Cancer Co-operative Clinical Trials Groups and COSA's collaborative role with key stakeholders including other NGO's Cancer Voices, Government agencies and Industry partners.

ANZUP an overview

© ANZUP 2020. All rights reserved.